Wire · opportunities
Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 2 October 2026 · Fusion42 review
HoneyNaps, an AI-based sleep health technology company, is expanding its clinical trial services by leveraging its SOMNUM AI sleep scoring platform to support pharmaceutical, medical device, and wellness sectors with consistent, objective sleep data for clinical trials. The company is now registered as a clinical research organization in Korea and aims to provide standardized sleep analysis to enhance clinical endpoint evaluation and foster digital biomarker development.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
You can now access consistent, AI-driven sleep data validated for clinical trials across pharma and device sectors, cutting variability that slows your research. This opens a new path to validate treatments and develop digital biomarkers faster with HoneyNaps' clinical research capabilities in Korea.
◆ Coverage
1 source · 1 Oct 2026
◆ Related on Wire
◆ Topics